The Efficacy of Berberine on Patients with Psoriasis

The Comparison of Efficacy of Berberine and Placebo on Skin Lesions of Psoriasis Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201201305069N6

Enrollment

Registered

2012-02-22

Start date

2011-07-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis. Psoriasis

Interventions

Intervention 1: Berberine cream, 50 gram twice a day for 6 months in first intervention group. Intervention 2: Placebo, 50 gram twice a day for 6 months in first intervention group.

Treatment - Drugs

Placebo, 50 gram twice a day for 6 months in first intervention group

Berberine cream, 50 gram twice a day for 6 months in first intervention group

Eligibility

Sex/Gender

All

Age

2 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: known case of psoriasis, not using of berberine cream during last 3 months, Exclusion criteria: pregnancy for females, sensitivity to components of barberry

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Psoriasis. Timepoint: before intervention and every month for sixth months. Method of measurement: Psoriasis Area Severity Index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaman Moosavian

Gachsaran Islamic Azad University

info@iaug.ac.ir+98 74 2333 4607

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026